StoneX Group’s Tevogen Bio Holdings TVGN Stock Holding History

StoneX Group’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-219	Closed	-$3.62K	–	1258
2025 Q4	$3.62K	Buy	+219	New	+$5.69K	﹤0.01%	1049
2023 Q1	–	Sell	-506	Closed	-$261K	–	703
2022 Q4	$261K	Buy	+506	New	+$259K	0.04%	338

Other funds holding TVGN

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

StoneX Group's TVGN Position: Q1 2026 in Review

StoneX Group sold out of Tevogen Bio Holdings (TVGN) in Q1 2026, closing a stake of 219 shares — an estimated $3.62K sold.

StoneX Group first reported a position in TVGN in Q4 2022 and held it in 2 quarters. The position peaked at $261K in Q4 2022. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

StoneX Group reported no remaining Tevogen Bio Holdings position as of Q1 2026 after selling out during the quarter.
StoneX Group sold 219 Tevogen Bio Holdings shares in Q1 2026, an estimated $3.62K.
StoneX Group first reported a position in Tevogen Bio Holdings in Q4 2022 and held it in 2 quarters.
StoneX Group's Tevogen Bio Holdings position peaked at $261K in Q4 2022.
30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.